This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Global Collagen And HA-Based Biomaterials Industry

NEW YORK, March 21, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Collagen and HA-Based Biomaterials Industry http://www.reportlinker.com/p080446/Global-Collagen-and-HA-Based-Biomaterials-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biomaterial

This report analyzes the worldwide markets for Collagen and HA-Based Biomaterials in US$ Million by the following Classification based on Application Areas: Collagen Based Biomaterials (Urinary Incontinence, Corneal Shields, Facial Aesthetic Dermal Fillers, & Wound Dressings), and Hyaluronic Acid Based Biomaterials (Viscosupplements, Viscoelastics, & Facial Aesthetic Dermal Implants). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

The report profiles 63 companies including many key and niche players such as ABBOTT, Alcon Laboratories, Inc., Allergan, Inc., Anika Therapeutics, Inc., Bausch & Lomb, Inc., Lifecore Biomedical, LLC, Q-Med AB, Sanofi SA, Genzyme, Seikagaku Corp., and Teijin Pharma Limited.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Product Definitions I-4Collagen-based Biomaterials I-4Urinary Incontinence I-4Corneal Shields I-4Facial Aesthetic Dermal Fillers I-4Wound Dressings I-4Hyaluronic Acid (HA)-based Biomaterials I-4Viscosupplements I-4Viscoelastics I-4Facial Aesthetic Dermal Fillers I-5

II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW II-1Outlook II-1Review of Major Segments II-1Collagen-Based Biomaterials II-1Urinary Incontinence II-1Corneal Shields II-2Facial Aesthetic Dermal fillers II-2Wound Dressings II-2Hyaluronic Acid-based Biomaterials II-2Viscosupplementation II-3Viscoelastics market II-3Facial Aesthetic Dermal Fillers II-3Select HA-Based Products in the Global Market II-3Regional Perspective II-4Growth Drivers- At a Glance II-4The Impact of Euro Zone Crisis on HA-Based Biomaterials Market II-4Increasing Difficulties on the Reimbursement Front II-4Increased Focus on Private Healthcare System II-5Challenges II-5Biomaterials Face Competition II-5Competitive Scenario II-5Leading Players in the Worldwide Collagen and HA-BasedBiomaterials Market II-6Table 1: Global Viscosupplements market (2011): PercentageBreakdown of Sales for Genzyme and Others (includescorresponding Graph/Chart) II-7World Collagen-based Wound Care Products (Global 2012)-Select Products and Manufacturers II-7Table 2: Global Advanced Wound Care Dressings Market (2012):Percentage Share Breakdown of Value Sales for Smith & Nephew,Convatec, Molnlycke, Coloplast, Systagenix, and Others(includes corresponding Graph/Chart) II-7

1 of 12

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs